Research programme: peptide therapeutics for pain - Johnson and Johnson Innovation/ University of Queensland
Alternative Names: Peptides derived from spider venomLatest Information Update: 28 Nov 2018
At a glance
- Originator Johnson & Johnson Innovation; University of Queensland
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain